DEPO & BVF product does not compete with Byetta. It can be only complimentary to it.
Byetta has no competition for at least 18 months. Byetta LAR [if approved] will not have any competition for many years. Even Novartis drug [if successful] will present a very limited competition to LAR and can be complimentary to it.
I gaurantee you...they can buy or sell stock within 30 day notice per SarOx. Alks wishes their directors would buy some !!! The co. doesnot have a trade restriction ...That only occurs during lockups, and there arent any.